Increased circulating CC chemokine levels in metabolic syndrome are reduced by low dose atorvastatin treatment: evidence from a randomised controlled trial.

Autoria(s): Loughrey, Brona; McGinty, Ann; Young, Ian; McCance, David; Powell, Lesley
Data(s)

2013
Identificador

http://pure.qub.ac.uk/portal/en/publications/increased-circulating-cc-chemokine-levels-in-metabolic-syndrome-are-reduced-by-low-dose-atorvastatin-treatment-evidence-from-a-randomised-controlled-trial(b95593ca-345e-4e64-b048-85304849a0df).html
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Loughrey , B , McGinty , A , Young , I , McCance , D & Powell , L 2013 , ' Increased circulating CC chemokine levels in metabolic syndrome are reduced by low dose atorvastatin treatment: evidence from a randomised controlled trial. ' Clinical Endocrinology .
Tipo

article
Acesso ao item digital